1. Hogan WR, et al. Towards a Consistent and Scientifically Accurate Drug Ontology, in Proceedings of the 4th International Conference on Biomedical Ontology (ICBO 2013), pp 68–73. Montreal, Quebec. Available at: http://ceur-ws.org/Vol-1060/icbo2013_submission_40.pdf
2. Hanna J, Joseph E, Brochhausen M, Hogan WR. Building a drug ontology based on RxNorm and other sources. Journal of Biomedical Semantics. 2013;4:44. doi: 10.1186/2041-1480-4-44 .
3. Hall R, Hanna J, Hogan WR. Maintaining the Drug Ontology: an Open-source, Structured Product Label API for the JVM, in International Conference on Biomedical Ontology 2013. Montreal, Quebec. Available at: http://www2.unb.ca/csas/data/ws/semantic-trilogy-workshops/papers/vdos/vdos2013_submission_8.pdf .
4. Huang J-H, Cheng H-S, Chung C-C, Hsieh M-H. Comparisons of Clinical Efficacy and Safety between the Brand- and Generic-name Fenofibrate in Patients with Hypertriglyceridemia. J Experiment Clin Med. 2013;5(4):136–8.
5. De Vuono A, Scicchitano F, Palleria C, Russo E, De Sarro G, Gallelli L. Lack of efficacy during the switch from brand to generic allopurinol. J Forensic Legal Med. 2013;20:540–2.